11:07 AM EDT, 09/05/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Thursday morning, declining 0.30% to 1,436.15 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor firm Sequans Communications ( SQNS ) and telecommunications company VEON (VEON), which advanced 11% and 4.5% respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and biotech firm BioNTech (BNTX), which were up 3.6% and 2.7% respectively.

The decliners from continental Europe were led by biopharmaceutical company Grifols ( GRFS ) and furniture maker Natuzzi (NTZ), which fell 7.7% and 4.7% respectively. They were followed by pharmaceutical firm Novo Nordisk ( NVO ) and telecommunications company Ericsson (ERIC), which were down 1.8% and 1.3% respectively.

From the UK and Ireland, the gainers were led by communications company WPP ( WPP ) and financial services company Barclays ( JJCTF ) , which rose 5.2% and 3.6% respectively. They were followed by telecommunications operator Vodafone Group ( VOD ) and utilities company National Grid ( NGG ) , which increased 2.6% and 2.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Biodexa Pharmaceuticals ( BDRX ) , which dropped 7% and 6% respectively. They were followed by pharmaceutical company AstraZeneca ( AZN ) and biopharmaceutical company Verona Pharma ( VRNA ) , which lost 3% each.